Economic impact of pharmaceutical interventions made in a renal transplant unit of a university hospital

Authors

DOI:

https://doi.org/10.30968/rbfhss.2024.151.0948

Abstract

Objective: To analyze the economic impact (EI) of pharmaceutical interventions (PI) made in a kidney transplant unit of a university hospital, through PI identification, EI classification and quantification of these. Methods: The observational cross-sectional study, descriptive study with retrospective data collection evaluated the PI records performed in a renal transplant infirmary in the period between June 2017 and June 2020, performed through the records on service-specific forms and database of the institution’s clinical pharmacy unit. The economic impact was classified as: increase in effectiveness (IE); low cost (LC); avoided cost (AC), calculated through methodologies already developed and adapted to the reality of the study, were verified the costs of purchases of medicines in the hospital’s own system and the values found adjusted to inflation of the years. The EI was classified according to the PI that had the potential to improve the medication use process and/or clinical effectiveness. In this classification, a real value of zero was assigned for the economic impact, even if the recommendation increased the value of the treatment. The RC was classified when the PI that included the cost was the one that felt the value of the treatment when compared with the previously administered therapeutic strategy without causing harm; and to classify as an AC the PI that was suggested to prevent or manage an Adverse Drug Event (ADE).Results: 873 PI were performed, of which 60.78% (n = 496) were of the type IE, 28.92% (n = 236) reduced cost and 10.30% (n = 84) avoided cost. The values found, were R$ 68,817.64 real (US$ 13.138,15 dollars) costs reduced, R$ 133,433.40 real (US$ 25.474,11 dollars) avoided, resulting in the final value of EI R$ 202,251.04 real (US$ 38.612,26 dollars). Conclusion: It is concluded that the implementation of Pharmaceutical interventions (IP) with Economic Impact (IE) and the use of pharmacoeconomic assessments function as an important strategy for optimizing resources and costs, combined with the search for ideal pharmacotherapy and improving clinical and economic.

Downloads

Download data is not yet available.

References

Associação Brasileira de Transplante de Órgãos. Manual de transplante renal. Available in:https://www.abto.org.br/abtov03/Upload/file/Profissional_Manual/manual_transplante_rim.pdf. Accessed on: October 15, 2023.

Oliveira FRP, Magalhães VP, Cavalcante RMA, Martins BCC, Guedes MM, Fonteles MMF, Silva LJ. (2019). Acompanhamento Farmacoterapêutico em Unidade de Internação pós-transplante: descrição e análise. Revista Eletrônica de Farmácia. 2019; 16(E).

Associação Brasileira de Transplante de Órgãos. Registro Brasileiro de Transplantes. Dimensionamento dos transplantes no Brasil e em cada estado 2013-2020. Available in: https://site.abto.org.br/wp-content/uploads/2021/03/rbt_2020_populacao-1-1.pdf. Accessed on: July 2, 2022.

Silva JK, Alves TL, Dantas GSV, Kelmer LM, Rios MA. Nursing Perception of Safety Culture: integrative review. Journal of Nursing UFPE/Revista de Enfermagem UFPE. 2016;10(10).

Pavan NFP, Magalhães ALP, Poncio DF, Ascari RA, Zanini PD, Knihs NDS, Silva OM. Cultura de segurança do paciente no transplante renal no oeste catarinense. Acta Paulista de Enfermagem. 2019;32, 398-405.

Santos COD, Lazaretto FZ, Lima LH, Azambuja MS, Millão LF. Reconciliação de medicamentos: processo de implantação em um complexo hospitalar com a utilização de sistema eletrônico. Saúde em Debate.2019; 43, 368-377.

Farmácia, CF. Resolução CFF nº 585, de 29 de agosto de 2013.Regulamenta as atribuições clínicas do farmacêutico Providências. Diário Oficial da União. 2013.

Gnatta, D. Atuação do farmacêutico clínico na equipe de transplante renal. Universidade Federal do Rio Grande do Sul. Porto Alegre.2019.

Neves RRS, Barbosa IC. Farmacoeconomia: uma estratégia para a gestão dos gastos com medicamentos no âmbito hospitalar. RACE-Revista de Administração do Cesmac. 2019; 5:194-217.

Oliveira TC, Vieira HKS, Elmescany SB, Gonçalves ST, Santos VRC. (2021). Estratégias de promoção para a segurança do paciente: Uma revisão integrativa quanto ao papel do farmacêutico na equipe multidisciplinar. Brazilian Journal of Development. 2021; 7(12).

Tiguman, GB, Ronaldo M. Economic impact of pharmaceutical interventions on healthcare services from Brazil: a systematic review. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde. 2020; 11(4), 512-512.

Packeiser, PB. (2014). Farmacoeconomia: uma ferramenta para a gestão dos gastos com medicamentos em hospitais públicos. Universidade Federal de Santa Maria Picada Café. 2014.

Wilkes S, Zaal RJ, Abdulla A. et al. Uma análise de custo-benefício de revisões de medicamentos em todo o hospital: um estudo de prevalência de período. Int J Clin Pharm. 2022; 44, 138–145. DOI: 10.1007/s11096-021-01323-1.

Nesbit TW, Shermock KM, Bobek MB, Capozzi DL, Flores PA, Leonard MC, Kvancz DA. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model. American journal of health-system pharmacy. 2001;58(9), 784-790.

Saokaew S, Maphanta S, Thangsomboon P. Impact of pharmacist’s interventions on cost of drug therapy in intensive care unit. Pharmacy practice 2009; 7(2), 81.

Gallagher J, Byrne S, Woods N, Lynch D, McCarthy S. Cost-outcome description of clinical pharmacist interventions in a university teaching hospital. BMC health services research. 2014; 14(1), 1-8.

Holanda, ANM. Análise clínica e econômica das recomendações farmacêuticas em unidade de terapia intensiva. Universidade Federal do Ceará, Fortaleza, 2019.

Porto S, Martins M, Mendes W, Travassos C. A magnitude financeira dos eventos adversos em hospitais no Brasil. Revista portuguesa de saúde pública. 2010; 74-80.

Brasil. Banco Central do Brasil. Calculadora do cidadão: Correção de valores. 2022. Available in:https://www3.bcb.gov.br/CALCIDADAO/publico/exibirFormCorrecaoValores.do?-method=exibirFormCorrecaoValores. Accessed on: April 30, 2022.

World Health Organization. The anatomical therapeutic chemical classification system with defined daily doses-ATC/DDD.2009.

Pinheiro MK, Chaves EF, Oliveira AB, Andrade CC, Bastos KX, Guedes MM. Pharmaceutical recommendations in a university hospital transplant unit. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde. 2019; 10(4), 361-361.

Silva KL. Atuação do farmacêutico na equipe de cuidado de pacientes em transplante renal: uma revisão integrativa. Universidade Federal do Rio Grande do Norte, Natal, 2022.

Martins BCC. Acompanhamento farmacoterapêutico de pacientes transplantados renais: da descrição aos desfechos clínicos. Universidade Federal do Ceará, Fortaleza, 2015.

Rijdt T, Willems L, Simoens S.Economic effects of clinical pharmacy interventions: a literature review. American Journal of Health-System Pharmacy. 2008; 65(12), 1161-1172.

Arantes T, Durval CC, Pinto VB. Avaliação da economia gerada por meio das intervenções farmacêuticas realizadas em um hospital universitário terciário de grande porte. Clinical and Biomedical Research. 2020; 40(2).

Brasil. Serviços farmacêuticos diretamente destinados ao paciente, à família e à comunidade: contextualização e arcabouço conceitual. Brasília: Conselho Federal de Farmácia. 2016; 200.

Published

2024-03-26

How to Cite

1.
MELO DT, OLIVEIRA AB, NETO JA, ANDRADE CC, LIMA AM, SOUSA GA, OLIVEIRA LM, FREITAS TC. Economic impact of pharmaceutical interventions made in a renal transplant unit of a university hospital. Rev Bras Farm Hosp Serv Saude [Internet]. 2024Mar.26 [cited 2024Jul.20];15(1):948. Available from: https://rbfhss.org.br/sbrafh/article/view/948

Issue

Section

ORIGINAL ARTICLES

Most read articles by the same author(s)